strong enrol growth trend date
indic narrow moat
updat forecast estim jul
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research jul
estim jul
price data jul
rate updat jul
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
core compet plan sponsor medicar
advantag program support consist excess econom
return last decad follow consolid
industri complet fund cut center medicar
medicaid servic on-going support expans
medicar advantag program think dug
narrow econom moat within competit nich local
scale within relev market expand provid presenc
regulatori expertis put firm superior competit
foot mani smaller player offer plan market
earli establish leadership posit
medicar advantag program account bulk
membership growth across manag care industri think
foresight continu benefit sharehold especi
polici discuss around expand medicar program
continu gain traction
commend manag maintain compani moat
firm sale aetna regulatori review
continu forg ahead deal fail gain approv
strategi defin multitud partnership joint
ventur differ area improv firm abil manag
cost care larg senior membership base wholli
own partner primari care clinic earli partnership
walgreen minor stake lead home health
hospic busi nation given manag flexibl
avenu tri lower cost care medicar advantag
nation dialogu around healthcar reform like intensifi
lead elect cycl contend humana
retain uniqu posit premier govern contractor
medicar advantag militari tricar system
think likelihood widespread industri disrupt
rel low posit potenti benefit
margin regulatori chang expans medicar
elig like benefit advantag program continu
expans medicaid like interest manag
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
one largest privat insur organ particip
medicar advantag program firm built nich special
government-sponsor program nearli medic membership
stem individu group medicar advantag medicaid
militari tricar program addit firm leader
stand-alon prescript drug plan offer senior enrol tradit
fee-for-servic medicar addit firm nascent commerci
offer focus risk arrang alongsid specialti offer
dental vision life smaller employ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
favor trend continu share
post solid second-quart result came
well ahead consensu expect larg
back better medic cost manag rais
fair valu estim narrow-moat firm per
share account out-performance
cash flow receiv sinc last updat still
consid share fairli valu roughli time
like first quarter enrol trend continu outpac
expect particularli firm individu medicar
advantag busi membership addit quarter
put segment pace expand midteen rate well
ahead market growth like nearer mid- high-singl
digit addit favor util trend segment
continu throughout second quarter retail
segment medic loss ratio came nearli
basi point lower model drive profit upsid
enterpris manag full-year guidanc
metric came roughli basi point result
still look rel conserv given typic second-
half declin seen year past
off-set commerci segment came
substanti wors forecast wipe much
segment profit howev rel size
book busi compar government-
sponsor organ limit overal import
enterpris million lower profit expect
segment larg driven varianc suggest
book return normal expens level
second half year
rais fair valu estim
per share impli roughli time
updat estim adjust earn
driven
combin modestli higher cash flow forecast given
favor cost trend seen date along take
account cash flow receiv sinc last updat
valuat underpin assumpt
continu grow medic insur
enrol roughli annual come five
year help combin above-market
growth medicar advantag enrol
estim per year modest declin firm
commerci group specialti book busi
assum premium increas rate consist
mid-single-digit cost trend assumpt medic loss
ratio remain rel consist five-year
forecast horizon final assum overal oper cost
see margin limit improv percent total
revenu normal volatil associ
assumpt result consolid revenu growth
averag near annual come year
addit model impli adjust ebitda margin
see modest eros come year remain line
compani histor averag approxim
growth rate combin healthi alloc share
repurchas drive ep growth toward annual rate
final manag signal confid busi
announc billion acceler share repurchas
program account roughli firm market
cap current valuat
concentr exposur government-sponsor
insur offer maintain high uncertainti rate
fundament busi
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
mid-single-digit rate assumpt result
per share fair valu estim roughli time
lower forecast earn ebitda respect
believ develop narrow econom moat
stem cost advantag network effect
believ inher manag care organ
achiev local scale necessari gener
excess return capit firm medic
membership roll smaller integr peer
develop core compet medicar
consolid presenc hand state
allow compani prosper strategi creat
competit advantag busi within
medicar advantag market peer found difficult
replic
typic shi away award moat
healthcar servic provid entiti reli heavili
medicar program fund reimburs
medicar advantag histori privat market solut
make dynam market somewhat differ
rather unilater dictat price medicar
provid arena medicar advantag fund
provid privat plan basi annual bid
benchmark averag roughli annual cost
fee-for-servic program benchmark set statut
stratifi cost quartil counti level
beyond highest quartil counti project
per-capita fee-for-servic spend benchmark
lower rate lowest cost area
benchmark rais give plan
flexibl price structur allow better
competit offer creat incent
compani lower cost high-util patient
ultim believ manag care busi
experi oper within regulatori framework
bull-cas scenario assum overal medic
enrol grow roughli annual help better
medicar advantag growth stabl commerci
offer assum premium growth line
mid-single-digit cost trend assumpt give compani
credit
control overal
oper expens consolid basi impli
compound annual revenu growth rate
termin oper margin beat
base-cas expect roughli basi point
assumpt result per share fair valu estim
roughli time higher estim
adjust earn ebitda respect
bear-cas outlook assum medic enrol
growth lag broader industri averag less
annual mid-single-digit cost trend
assumpt lead roughli revenu growth annual
averag margin declin across firm busi
segment assum firm termin ebitda margin
fall short base-cas expect roughli basi
point see earn growth fail surpass
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
manag care specif need medicar
patient popul like succeed long
run clear leader front
nation level medicar advantag rel
consolid top insur account nearli
cover popul account
roughli total howev vast major
enrol local plan nation comparison doesnt tell
whole stori compani typic
number one two insur counti
offer plan compet heavili state
state firm overal enrol share fall closer
averag import develop
leverag rate paid local provid also
creat effici manag higher cost popul
specif texa florida humana work
develop wholli own partner provid organ
creat seamless relationship
patient clinic
within structur believ two relev moat sourc
emerg -- cost advantag network effect
advantag thought two way relat
back size insur book busi first
larger membership base allow greater central fix
cost leverag increas profit potenti margin
member overal enterpris second larger
membership base allow greater negoti leverag
versu provid insur need creat plan
network allow lower medic cost per member
opportun lower premium improv benefit
offer secur enrol growth rare instanc
healthcar system focus build local scale
shift balanc power relationship given
much higher level concentr found
industri larg think scale frequent tip
insur favor particularli given plan abil
network effect also play intertwin role
patient payer provid incumb plan
enrol grow relationship three
entiti becom valuabl time patient
becom rel afford plan invest
broader swath benefit member payer
expand enrol allow greater per-memb
profit attract offer either
better price entic benefit packag
provid particip expand plan network
provid access greater patient volum key
compon profit busi high fix cost
short run dynam creat barrier entri
would-b competitor put togeth attract
price provid network new geographi prohibit
difficult without membership pool vice versa
addit think incumb benefit
star-rat system provid addit econom
patient awar plan score highli
measur outcom process patient experi
access plan market longer
shown typic score higher averag star-rat
score like attribut contract
consolid effort better rate manag
experienc plan star system act
market tool success plan along provid
increment payment allow effect oper
offer comprehens benefit packag potenti
member help spur enrol growth
membership contract rate
higher compar industrywid averag
nearer plan year
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
notic consolid financi posit
compani similarli futur enrol industri
level may face futur cyclic challeng associ
weaken economi rise uninsur rate medicar
advantag uniqu insul macro shift due
natur membership base
final moatworthi right think
ownership fourth largest pharmaci
benefit manag grow presenc provid
space help support strong outcom cost
manag need run success plan
direct ownership partnership arrang
firm forefront build
comprehens value-bas offer help firm
better manag overal cost burden shift
financi risk provid notabl manag
claim membership current
manag full-risk arrang provid
shown produc lower medic loss ratio
think underli sourc underpin econom
moat manag care space larg stabl
success post attract return capit
last five year character
on-going chang healthcar industri importantli
firm growth larg organ littl goodwil
balanc sheet depress report return look
forward view scenario firm underli
cost advantag network effect materi erod
substanti strengthen unlik durat
five-year forecast period howev uniqu
sensit propos chang implement
fund medicar advantag tricar program
demograph suggest secular enrol growth
like come lower-margin medicar cohort
forese futur view result mix
effect sever enough suggest firm underli
competit advantag weaken addit
commerci mix increasingli small portion profit
firm doubt neg mix effect would
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
leadership posit fast-grow
medicar advantag market posit firm
captur above-market enrol growth time
owhil window horizont merger opportun
manag care appear close think
asset particip industri
provid asset
acceler stake kindr
add compani compet care
senior popul
concentr exposur feder state
program fund sourc revenu creat
acut risk busi feder deficit continu
expand
ohealthcar reform like recur topic
throughout upcom elect cycl
could creat increas stock volatil pose real
fundament threat public-opt propos
opolici propos look curb chang use
rebat throughout system could creat disrupt
throughout suppli chain hinder pbm efficaci
profit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
balanc sheet solid shape compani
gross debt balanc equat roughli time adjust
ebitda modestli higher histor leverag level
manag view compani maintain
debt capit ratio roughli consist
manag long-term target addit
compani tend keep roughli million cash hand
parent give busi ampl liquid
manag focus consist dividend
rais opportunist share buyback return excess
capit sharehold
concentr exposur government-sponsor
insur plan combin ever-pres risk
associ polici uncertainti manag care
space warrant high uncertainti rate compani
nearli firm non-militari membership tie
way govern fund medicar advantag
stand-alon drug plan medicaid etc chang feder
state budget prioriti pose acut risk firm
mandat fund cut medicar
advantag program complet limit
impact firm remain uniqu expos
unilater chang diversifi peer like
better posit handl hand
rhetor around healthcar reform like intensifi
elect season think passag
implement sweep chang remain remot
possibl think chang margin like
modif afford act continu
expans medicaid creat earli buy-in option
medicar wouldnt surpris see privat
insur play role improv coverag
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
give manag humana standard mark
stewardship current ceo bruce broussard overseen
substanti valu creation sinc elev role
think firm abil report consist strong
result backdrop chang healthcar polici
landscap impress credit manag polici
firm board put togeth well-structur incent
scheme align manag interest
sharehold view annual bonu payment
measur adjust ep net promot score
strateg measur firm long-term incent
program mix option restrict stock
measur
three-year cumul return invest capit target
along stock perform benchmark peer
think combin provid balanc
growth profit reinvest need ensur
manag decis align long-term goal
sharehold
final major consider stewardship
methodolog pleas compani polici
separ board chairman ceo posit
repres date owner name posit common share held report holder issuer
american fund growth fund amer
capit research manag compani
fidel manag research compani
share
fund
share
fund
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
favor trend continu share
post solid second-quart result came
well ahead consensu expect larg
back better medic cost manag rais
fair valu estim narrow-moat firm per
share account out-performance
cash flow receiv sinc last updat still
consid share fairli valu roughli time
like first quarter enrol trend continu outpac
expect particularli firm individu medicar
advantag busi membership addit quarter
put segment pace expand midteen rate well
ahead market growth like nearer mid- high-singl
digit addit favor util trend segment
continu throughout second quarter retail
segment medic loss ratio came nearli
basi point lower model drive profit upsid
enterpris manag full-year guidanc
metric came roughli basi point result
still look rel conserv given typic second-
half declin seen year past
off-set commerci segment came
substanti wors forecast wipe much
segment profit howev rel size
book busi compar government-
sponsor organ limit overal import
enterpris million lower profit expect
segment larg driven varianc suggest
book return normal expens level
second half year
final manag signal confid busi
announc billion acceler share repurchas
program account roughli firm market
cap current valuat
first report juli axio trump administr
plan final propos rule alter flow
drug rebat purchas medicar part plan
rule would chang busi model
pharmaci benefit manag requir negoti
discount pass directli beneficiari
point sale rather use mechan lower
cost insur plan overal led ralli
pbms/insur distributor drug stock sank
investor wonder presid donald trump focu
turn next take rebat reform tabl put
pressur congress particularli bipartisan senat
financ committe team chuck grassley ron wyden
reveal drug-pric packag month stand
chanc pass chamber potenti reform
like reduc cost medicar patient also look
modest payer drug firm
think remain propos review
budget offic -- medicar part intern price
index -- unlik implement even final
congress power block rule judici review
could find massiv demonstr overextens
author center medicar medicaid
innov cmmi
altern expect senat drug price packag
could includ part reform also includ cap
out-of-pocket spend medicar part anticip
propos would see widespread support
policymak result higher likelihood
success think chang would manag
drug firm effect achiev bipartisan
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
polici goal lower healthcar cost american
addit detail analysi effect
rebat rule elimin pleas see report rebat
result put track
narrow-moat report first-quart result
modestli ahead expect due better
medicar advantag enrol effect control
oper cost across busi adjust
model dont expect meaning chang
per share fair valu estim impli valuat
multipl roughli time estim adjust
enrol trend across busi appear stronger
expect medicar advantag book grow
well ahead broader industri domin
market abil consist win market
share underpin narrow econom moat rate base
perform open enrol period humana
pois add nearli member
cours year compar market growth
averag nearer year date estim
commerci book lower origin anticip
stronger growth employ self-fund
offer claim firm commerci book
track slightli ahead expect util
come better expect leav medic loss ratio
line forecast year
dynam pose modest headwind busi
health insur fee unlik suspend
manag indic next year earn
growth like fall long-term
growth target alreadi includ fee model
impli modestli larger bottom-lin impact
anticip next year long-run expect
least ep growth remain unchang
margin tweak assumpt
substanti impact cash flow forecast result
upgrad narrow moat affirm anthem
continu refresh managed-car coverag
upgrad narrow moat rate
rais moat trend outlook anthem
stabl neg re-affirmed narrow
moat rate rais fair valu estim
think success carv
competit advantag market nich medicar
advantag firm garner market share level
approach nearli third enrolle state
largest presenc help support cost advantag
network effect underpin narrow econom
moat result competit strength humana
post return exceed cost capit
consist last decad program rate
cut rearview mirror medicare-elig
demograph continu gain share next five
year believ firm underli moat worthi
stabl trend rate combin moat upgrad
favor cash flow forecast drive fair valu
estim per share
rais fair valu estim
per share larg reflect higher cash flow
estim combin new stabl moat trend
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
feb add nearli live firm
medic benefit busi seen acceler
last year compani part prescript drug
plan offer undermin industrywid price
membership follow approxim loss last year
final underli cost volatil
associ health insur fee moratorium
overal segment-level oper margin busi
appear roughli consist result
encourag firm consist despit expect
weak part modest enrol loss
licens allow domin primari state
oper encourag strateg vision
laid ceo gail boudreaux includ return
growth firm commerci segment improv
pharmaci cost structur acceler launch
in-hous pharmaci benefit manag willing
partner fellow plan expand reach new
state growth trajectori laid
recent investor day look somewhat aggress
happi see concret stand-alon strategi firm
attempt acquir fail
despit weaker part commerci membership
report full-year result larg track
expect provid outlook appear
bracket consensu project dont
intend make sizabl chang model result
today releas may updat fair valu estim
reassess competit landscap managed-
care industri follow merger cvs/aetna
cigna/express script intend leav no-
moat neg trend rate place
firm strength continu eman medicar
advantag book busi slate see market
share gain come year manag saw strong
initi respons offer individu market
indic nearli gross sale
open enrol came win versu compet
plan encourag continu acceler
membership growth compani
expect year far surpass roughli rate
seen medicaid also expect posit
contributor compani fulli implement
newli manag medicaid contract florida
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
